Yellow Dye 5 vs Carrageenan: which is worse?

What is Yellow Dye 5?

Yellow Dye 5 (tartrazine) is a synthetic lemon-yellow azo dye derived from petroleum. It produces a bright, stable yellow color in acidic conditions and is one of the most widely used yellow dyes globally. Its chemical formula is C16H9N4Na3O9S2.

What is Carrageenan?

Carrageenan is a polysaccharide extracted from red seaweed (primarily Chondrus crispus and Eucheuma species). Used as a thickener, gelling agent, and stabilizer in food and personal care products. Food-grade carrageenan (undegraded) is different from degraded carrageenan (poligeenan), which is not food-grade and is a known inflammatory agent.

Documented risks

Yellow Dye 5: Yellow Dye 5 was one of six dyes studied in the landmark 2007 McCann et al. study in The Lancet. The study found statistically significant increases in hyperactivity in children ages 3 and 8–9 given a mixture containing tartrazine and sodium benzoate. EFSA reviewed the evidence and confirmed the effect was real, mandating the EU warning label from 2010. A 2012 review in Neurotherapeutics (Arnold et al.) confirmed that artificial food colors including tartrazine have a small but statistically significant adverse effect on children's behavior that is not confined to those with diagnosed ADHD. Tartrazine is one of the most documented causes of food dye hypersensitivity. Cross-reactivity with aspirin (acetylsalicylic acid, ASA) is well established in allergy literature: individuals with aspirin hypersensitivity have elevated risk of reacting to tartrazine. Symptoms include urticaria, angioedema, rhinitis, and in rare cases anaphylaxis. Prevalence of tartrazine sensitivity is estimated at 0.1% of the population but higher in aspirin-sensitive individuals. Because of this known hypersensitivity risk, the FDA specifically requires Yellow No. 5 to be declared by name on US food labels — an exceptional requirement not applied to most other additives, reflecting the FDA's acknowledgment of this real clinical concern. EFSA's 2009 re-evaluation found no evidence of genotoxicity in standard test systems at food use levels, setting an ADI of 7.5 mg/kg body weight, but noted in vitro evidence at higher doses. In April 2025, the FDA announced plans to phase out Yellow 5 along with other petroleum-based dyes.

Carrageenan: Carrageenan safety has been disputed for decades, centering on the distinction between undegraded (food-grade, high-molecular-weight) carrageenan and degraded carrageenan (poligeenan). Poligeenan, produced by acid hydrolysis, is a known inflammatory and carcinogenic agent in animals. Food-grade carrageenan is a different molecule, but critics argue it can partially degrade in the acidic stomach environment. Dr. Joanne Tobacman at the University of Illinois has published multiple studies on carrageenan-induced inflammation. A 2001 paper in Environmental Health Perspectives (PMC1240867) demonstrated that food-grade carrageenan activates inflammatory signaling pathways (NF-κB) in human intestinal cells, inhibits insulin signaling, and causes intestinal injury in animal models. Her 2012 review in the Journal of Diabetes Research summarized multiple animal studies showing intestinal inflammation, ulcerations, and neoplasms. A 2017 review in Environmental Health Perspectives (Bhide et al.) found carrageenan activated NF-κB inflammatory pathways and could potentially exacerbate inflammatory bowel disease (IBD) in susceptible individuals. Major regulatory bodies including EFSA (comprehensive 2018 re-evaluation) and the WHO/FAO JECFA have consistently concluded that undegraded food-grade carrageenan does not cause cancer or significant harm at typical food use levels in healthy adults. However, the EU precautionary ban in infant formula (2018) acknowledged that infants' developing digestive systems may be more vulnerable to carrageenan's potential effects, and insufficient evidence of safety existed for this specific high-risk population. The USDA's removal of carrageenan from Organic certification (2018) reflected organic industry stakeholder concern despite the continued regulatory permission. Individuals with IBD or gut sensitivity may have reason to avoid carrageenan based on in vitro and animal data, even if the general population safety at food use levels is defended by EFSA and JECFA.